The attack on sugary sweetened beverages is back, as New York City Mayor Bill de Blasio has voiced his support for limiting the size of sugary drinks. Although de Blasio has not yet decided how he is going to approach this Continue reading
An op-ed in Forbes.com wonders why clean, safe, zero-carbon-footprint nuclear energy has so few friends in high places these days. ACSH advisor and co-author of our publication on nuclear energy has some thoughts, but no answers. Continue reading
Dr. Gilbert Ross in The Parliament Magazine, October 13, 2014.
The EU’s five-year process of revising the tobacco products directive (TPD) has resulted in a nearly-unmitigated disaster. Eschewing at every opportunity science-based (or even rational) policy, a conflicted, unaccountable bunch of commissars, (I mean commissioners) working in secret and in concert with like-minded petty Continue reading
r. Gilbert Ross in the EUReporter, October 13, 2014.
The EU’s five-year process of revising the Tobacco Products Directive (TPD) has resulted in a nearly-unmitigated disaster. Eschewing at every opportunity science-based (or even rational) policy, a conflicted, Continue reading
As we mentioned earlier this week, ACSH’s Dr. Josh Bloom is not a big fan of how the CDC is attempting to control the spread of Ebola.
He has written an op-ed on Science 2.0, entitled “Preventing Ebola: Screen — Or Screen Door?” which reflects this rather clearly. Continue reading
A surprising new front in the war against fracking: Texas, the heart of the fossil fuel industry. Although the anti-frackers (?fractavists) are as scientifically clueless as their New York State fellow-activists, the upcoming vote may be close. Continue reading
Although the actual impact of Ebola on the world so far is minuscule, it has been the top news story much of the time over the past few weeks.
We at ACSH are no strangers to media scares and frenzies, and it is clear that this is one of the main drivers here. But it is not the only one. Continue reading
The Biotechnology Industry Organization (BIO) has taken issue with a recent 60 Minutes piece about the high price of new oncology drugs.
The BIO response was “It is unfortunate that CBS has chosen to attack the price of specialty cancer medications while ignoring the value created by these drugs for patients and the health care system. Cancer patients today are able to live longer and enjoy a higher quality of life than ever before thanks to medicines made by biopharmaceutical research companies.” Continue reading
The mentally-challenged NYC Council will consider a proposal to ban flavored e-liquid in NYC. In contrast to last year’s vote restricting indoor e-cig/vapor use, the ramifications of this ban would be huge, and hugely harmful, to public health and the nascent industry. Continue reading
This past June, former Mayor Michael Bloomberg’s ban on “super-sized sodas” was put to rest, but if you thought that was the end of the attack on soda, you were mistaken. Currently, two taxes on sugary beverages Continue reading